Lv32
338 积分 2024-09-01 加入
Efficacy and safety of SGLT2 inhibitors with and without glucagon-like peptide 1 receptor agonists: a SMART-C collaborative meta-analysis of randomised controlled trials
1小时前
待确认
Applications of SGLT2 inhibitors beyond glycaemic control
2小时前
已完结
Kidney and heart failure outcomes associated with SGLT2 inhibitor use
2小时前
已完结
Effect of SGLT2 inhibitors on heart failure outcomes and cardiovascular death across the cardiometabolic disease spectrum: a systematic review and meta-analysis
2小时前
已完结
SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications
2小时前
已完结
A Systematic Review and Meta-analysis on the Safety and Efficacy of Sodium–Glucose Cotransporter 2 Inhibitor Use in Hospitalized Patients
4小时前
已完结
American Association of Clinical Endocrinology Consensus Statement: Comprehensive Type 2 Diabetes Management Algorithm – 2023 Update
5小时前
已完结
Evaluation and Management of Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2024 Clinical Practice Guideline
5小时前
已完结
Circulating Metabolites and Cardiovascular Disease in Asians with Chronic Kidney Disease
17天前
已完结
Lipoprotein Subfractions Predict All-cause and Cardiovascular Mortality in CKD Patients Undergoing Hemodialysis: A Prospective Cohort Study Based on NMR Metabolomics
17天前
已完结
皖公网安备34019202002308
